LAVANOX-Serag® wound spray gel is used to clean and moisten acute and chronic wounds and supports autolytic wound débridement. Hydrogels are extremely suitable for moistening wounds and for use on preservative inlays and dressings. Thanks to their effective cleansing, they promote the physiological conditions required for wound healing.
Method of use
Before using the gel for the first time and at every dressing change, clean the wound thoroughly with LAVANOX-Serag® wound irrigation solution or LAVANOX-Serag® wound spray. Shake the bottle of LAVANOX-Serag® wound spray gel well before use and apply directly to the wound by spraying several times in rapid succession. Immediately after it has been sprayed on, the solution solidifies to form a well-adhering hydrogel. LAVANOX-Serag® wound spray gel can be used in combination with gauze compresses, adhesive plasters and other dressing materials. There are no restrictions on the frequency or duration of use.
Innovative dosage form: Hydrogel for use as a spray
After opening: 12 weeks
Unopened: 2 years from date of manufacture
Water, <0.06% sodium hypochlorite (electrochemically activated mineral salt solution), lithium magnesium sodium silicate
Production and stability
Simplified diagram of a bacterium after the application of LAVANOX-Serag®
Sodium hypochlorite (NaOCl) is an oxidising agent that splits off and releases oxygen (O). This free oxygen damages bacterial, viral and fungal cell membranes and increases their permeability. The membrane can no longer withstand the osmotic pressure and the microorganism is inactivated.1,3,4 After oxygen is split off from the sodium hypochlorite, the substance reverts to its natural state of water and salt.4 Sodium hypochlorite is also produced naturally in the body by lysosomes to defend against micro-organisms and is an important part of phagocytosis in the body’s immune defence mechanisms. But the concentration of "active chlorine" produced is so low that human tissues are not damaged.3
Electrochemical activation (ECA) involves passing an aqueous mineral salt solution through several electrolysis cells. ECA technology represents the further development and optimisation of membrane electrolysis for use in the eld of medicine.
The solutions have particular physicochemical and catalytic properties and are well-established in the decontamination and irrigation of wounds and in keeping wounds moist.
Stable and very well-tolerated solutions are produced from natural starting materials such as water and mineral salts.
1 Brill FHH. Data on file. 2013
2 Kammerlander G, Assadian O, Eberlein T, Zweitmuller P, Luchsinger S, Andriessen A. A clinical evaluation of the efficacy and safety of singlet oxygen in cleansing and disinfecting stagnating wounds. J Wound Care. 2011 Apr;20(4):149-50
3 Kramer A. Wundantiseptik. ARS MEDICI. 2016 (9): 419-426
4 Lorberth J, Massa W. Zu den chemischen Grundlagen der Wirkung von Steralythen. Wund Management 2012 (3): 52-54
5 Möller A, Splieth B, Schmitz M, Eberlein T. Produkte auf Basis elektrochemischer Aktivierung (ECA) im erweiterten medizinischen Einsatz. Medizin & Praxis. 2016 (in Druck)